Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths during October 2023 to September 2024. People 65 years and older accounted for the majority of hospitalizations and deaths.
COVID-19 has continued to affect the US health care system through outpatient visits, hospitalizations, and deaths long after the public health emergency declaration ended in May 2023. SARS-CoV-2 circulation has added pressure during winter respiratory illness seasons while other respiratory viruses continue to circulate.
Current estimates feed decisions on resource allocation and public health policy, but they cannot react to what they cannot see. Case reporting to the US Centers for Disease Control and Prevention ended with the end of the COVID-19 public health emergency, removing a national stream of case-based data used earlier in the pandemic.
Mortality tracking often relies on death certificates listing COVID-19 as an underlying or contributing cause of death. Relaxed reporting requirements, new variants, and reduced testing complicate estimates of disease burden. Even symptomatic people often do not seek care or testing, creating gaps in attributable illness and death.
In the study, “Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths in the US From October 2022 to September 2024,” published in JAMA Internal Medicine, researchers applied hierarchical Bayesian modeling and probabilistic mathematical multiplier models to estimate COVID-19-associated illnesses, outpatient visits, hospitalizations, and deaths in the US from October 2022 to September 2024.
COVID-19 Hospitalization Surveillance Network (COVID-NET) data came from 89 counties and jurisdictional equivalents in 12 states, covering approximately 10% of the US population. Data included 94,363 participants for October 2022 to September 2023 and 72,176 participants for October 2023 to September 2024.
Concentration of severe outcomes
During the 2022–2023 period, there were an estimated 43.6 million COVID-19-associated illnesses, 10.0 million outpatient visits, 1.1 million hospitalizations, and 101,300 deaths.
During the 2023–2024 period, there were an estimated 33.0 million COVID-19-associated illnesses, 7.7 million outpatient visits, 879,100 hospitalizations, and 100,800 deaths.
Adults aged 65 years and older made up 17.7% of the total US population during 2023–2024 and accounted for 47.9% of COVID-19-associated illnesses. 65 and older accounted for 64.3% of COVID-19-associated outpatient visits, 67.6% of associated hospitalizations, and 81.2% of deaths.
Prevention and treatment gaps
Vaccination and early antiviral treatment may prevent severe COVID-19 consequences. Estimates in 2024 indicate 18% of US adults aged 18 years and older and 30% of nursing home residents received a recent COVID-19 vaccine. Outpatient antiviral treatment in 2024 reached fewer than one-half of adults aged 65 years and older.
Assumptions can begin to shape personal choices as well as national policy when a surveillance network stops reporting and there is a real danger that people will assume the risk is gone. COVID-19 hasn’t gone away, and vaccines are still actively preventing severe illness and death.
News
Scientists discover natural ‘brake’ that could stop harmful inflammation
Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases affecting millions worldwide. Inflammation is the [...]
A Forgotten Molecule Could Revive Failing Antifungal Drugs and Save Millions of Lives
Scientists have uncovered a way to make existing antifungal drugs work again against deadly, drug-resistant fungi. Fungal infections claim millions of lives worldwide each year, and current medical treatments are failing to keep pace. [...]
Scientists Trap Thyme’s Healing Power in Tiny Capsules
A new micro-encapsulation breakthrough could turn thyme’s powerful health benefits into safer, smarter nanodoses. Thyme extract is often praised for its wide range of health benefits, giving it a reputation as a natural medicinal [...]
Scientists Develop Spray-On Powder That Instantly Seals Life-Threatening Wounds
KAIST scientists have created a fast-acting, stable powder hemostat that stops bleeding in one second and could significantly improve survival in combat and emergency medicine. Severe blood loss remains the primary cause of death from [...]
Oceans Are Struggling To Absorb Carbon As Microplastics Flood Their Waters
New research points to an unexpected way plastic pollution may be influencing Earth’s climate system. A recent study suggests that microscopic plastic pollution is reducing the ocean’s capacity to take in carbon dioxide, a [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from Frank Boehm
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
New Book! NanoMedical Brain/Cloud Interface – Explorations and Implications
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
Miller School Researchers Pioneer Nanovanilloid-Based Brain Cooling for Traumatic Injury
A multidisciplinary team at the University of Miami Miller School of Medicine has developed a breakthrough nanodrug platform that may prove beneficial for rapid, targeted therapeutic hypothermia after traumatic brain injury (TBI). Their work, published in ACS [...]
COVID-19 still claims more than 100,000 US lives each year
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths [...]
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
